In this episode, host Dr. Peter Weir speaks with Molly Becky, DNP, a women’s health nurse practitioner at the University of Utah Health Midlife Women’s Health & Menopause Program. As a Menopause Society Certified Practitioner, Molly brings expertise in evidence-based care for women in midlife, including the use of hormone therapies and management of menopausal symptoms. Their conversation covers a broad range of health concerns affecting women during this stage of life, while also highlighting recent FDA changes and exploring how these updates influence clinical practice and decision-making to ensure safe, effective, and up-to-date care.
Topics discussed include:
• Why HRT Was Renamed
• Perimenopause vs Menopause
• Diagnosing and Lab Panels - When Symptoms Beat Labs
• What Counts as MHT
• Progesterone and the Uterus
• Who Should Start MHT
• Contraindications Overview
• MHT vs Birth Control
• Clot Risk and Dosing
• WHI Study Revisited
• Modern Hormone Formulations
• Misconceptions and Counseling
• Nonhormonal Medication Options
• Future Therapies - Testosterone
• Compounding Pros and Cons
• Online Influencers and Resources
At the conclusion of the podcast, learners should be able to:
1. Have a greater understanding of perimenopause and menopause and be able to evaluate appropriate patient selection for traditional menopause hormone therapy (MHT), including FDA-approved indications for estrogen and progesterone.
2. Assess the individual risks and contraindications of MHT to patients, support safe, evidence-based prescribing and effective patient counseling.
Learn More – Links to Resources
Upcoming CME Training about Menopause Care 2026
• June and October CME sessions in 2026, hosted by University of Utah Health
Hormone Therapy Resources
Women's Health Research Studies
Women’s Health Midlife Care
Episode Timeline
00:53 Why MHT Not HRT
01:36 Perimenopause vs Menopause
04:19 Diagnosing
05:05 Lab Interpretation Pitfalls
07:20 Treating Symptoms Despite Normal Labs
08:58 Estrogen Progesterone Basics
12:52 Who Should Avoid MHT
15:03 Contraindications and OCP Differences
17:19 Clot Risk and Patch Safety
19:22 WHI Study Revisited
22:23 Modern Hormone Formulations
23:24 Top Menopause Symptoms
25:39 Misconceptions and Counseling
26:53 Nonhormonal Medication
33:15 Future Therapies - Testosterone
35:01 Compounding and DHEA
37:57 Influencers